-
04.25.2025 Seikagaku and Ono Reach a Basic Agreement Related to Co-development and Marketing Collaboration on Gel-One in Japan
（3,945KB）
-
03.26.2025 Seikagaku Announces Revision of Forecast of Full-Year Consolidated Financial Results for the Fiscal Year Ending March 31, 2025
（3,853KB）
-
03.12.2025 Seikagaku Announces Receipt of a Complete Response Letter Concerning the Biologics License Application in the U.S. for SI-6603 (Generic Name: Condoliase)
（133KB）
-
02.21.2025 Seikagaku Announces Initiation of Phase III Clinical Studies of Gel-One, a Treatment of Osteoarthritis, in Japan
（3,943KB）
Seikagaku News Releases are issued to provide stakeholders with the most up-to-date information related to our company.
-
04.18.2025 Seikagaku will announce the financial results for the Fiscal Year ended March 31, 2025 at 16:00 on May 13, 2025
-
02.07.2025 Seikagaku announced the financial results for the Third Quarter of the Fiscal Year ending March 31, 2025
-
01.24.2025 Seikagaku will announce the financial results for the Third Quarter of the Fiscal Year ending March 31, 2025 at 16:00 on February 7, 2025
-
12.02.2024 New Message from President & CEO
